logo
Plus   Neg
Share
Email

HSBC H1 Profit Up, Plans Upto $1 Bln Buyback; Warns On RoTE View; CEO Steps Down

Asia-focused lender HSBC Holdings Plc (HSBC,HSBA.L) reported Monday that its first-half profit attributable to the ordinary shareholders of the parent company grew to $8.51 billion from last year's $7.17 billion. Earnings per share were $0.42, up from $0.36 a year ago.

Profit before tax went up 15.8 percent to $12.41 billion from prior year's $10.71 billion. The latest results included $828 million dilution gain recognised on the completion of the merger of associate The Saudi British Bank with Alawwal bank in Saudi Arabia. It also included a provision of $615 million related to the mis-selling of payment protection insurance, and $248 million of severance costs arising from cost efficiency measures across its global businesses and functions.

Adjusted profit before tax was $12.2 billion, compared to $11.72 billion last year.

Revenue grew 7.6 percent to $29.37 billion from prior year's $27.29 billion. Adjusted revenue went up 8 percent to $28.50 billion.

Further, the company said it intends to initiate a share buy-back of up to $1 billion, which is expected to commence shortly.

Regarding 2020 financial targets, the company now said that based on the prevailing outlook for interest rates and revenue headwinds in certain segments, it does not expect to achieve 6 percent RoTE target in the US by 2020.

Separately, HSBC said John Flint has stepped down as Group Chief Executive and as a Director by mutual agreement with the Board.

The company appointed Noel Quinn, currently Chief Executive, Global Commercial Banking, as interim Group Chief Executive and as a Director of HSBC Holdings.

The Board has initiated a process to find a new Group Chief Executive. The Board will be considering internal and external candidates.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Food and Drug Administration or FDA announced on its website that pharma major Pfizer, Inc. issued recall of two lots of tablets meant to treat acute migraine in adults for concerns over bacteria infection. The pharma company is recalling two lots of Relpax (eletriptan hydrobromide) 40 mg tablets for potential presence of Genus Pseudomonas and Burkholderia bacteria. Cosmetics company Revlon Inc. (REV) is reportedly considering a potential sale of parts or all of its business. According to Bloomberg, Revlon has retained financial advisers from Goldman Sachs Group Inc. to explore strategic alternatives. No deal has been reached yet, but Revlon is exploring all... China's Lenovo Group Ltd. warned it may have to raise prices of its products if the U.S. moves ahead with the decision to impose additional tariffs on Chinese goods, according to a report by Reuters. The warning by Lenovo, the world's largest PC maker, comes amid the escalating trade war between the U.S. and China that has raised concerns about the global economic outlook.
Follow RTT